The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Prognostic relevance of circulating tumor cells (CTC) before adjuvant chemotherapy in patients with breast cancer: Results of the German SUCCESS trial.
J. K. Jueckstock
No relevant relationships to disclose
B. K. Rack
No relevant relationships to disclose
T. Zwingers
No relevant relationships to disclose
P. G. M. Hepp
No relevant relationships to disclose
A. Schneeweiss
No relevant relationships to disclose
M. W. Beckmann
No relevant relationships to disclose
W. Lichtenegger
No relevant relationships to disclose
H. L. Sommer
No relevant relationships to disclose
K. Pantel
No relevant relationships to disclose
H. Tesch
No relevant relationships to disclose
H. Forstbauer
No relevant relationships to disclose
R. Lorenz
No relevant relationships to disclose
M. Rezai
No relevant relationships to disclose
J. K. Neugebauer
No relevant relationships to disclose
U. Andergassen
No relevant relationships to disclose
K. Friese
No relevant relationships to disclose
W. Janni
No relevant relationships to disclose